Center Scholars
Training is one of the most vital missions of our Center, and our Center Scholars represent the future leaders of the field.
Our Scholars are a group of trainees and early-career professionals whose research interests and goals align with those of the CDSE.
If you are a master's or doctoral student or a clinical fellow and you are interested in becoming a Center Scholar, please contact us.
Current Center Scholars
Carissa White Dukes, MPH
Advisor: Caleb Alexander, MD, MS
Research Focus: Pharmacoepidemiology, Precision Psychiatry
Carissa White Dukes is a DrPH student pursuing the custom concentration track with a focus in pharmacoepidemiology and mental health. She is a dedicated pharmacoepidemiologist having worked in industry since graduating from Indiana University Richard Fairbanks School of Public Health with her Master of Public Health (MPH) degree in 2015. She has a passion for improving mental health outcomes through rigorous research and data analysis and is driven by the potential of pharmacoepidemiology to inform and improve psychiatric drug safety and efficacy. In her current role she analyzes large-scale patient data to understand patient populations, identify trends, risks, and opportunities for precision medicine in mental health. She is committed to advancing the understanding of mental health conditions and the factors that influence their prevalence, treatment, and outcomes. Her research efforts have spanned a wide range of topics, from investigating the safety and efficacy of psychotropic medications to examining the impact of social determinants on mental health disparities. With a Doctor of Public Health (DrPH) degree, she hopes to gain the academic background and practical experience necessary to tackle complex issues at the intersection of pharmaceuticals and epidemiology in mental health. She also plans to use her acquired skills to contribute to the advancement of precision psychiatry for improved outcomes.
Joseph Hwang, MD, MSc
Advisors: Caleb Alexander, MD, MS & Todd Fojo, MD, MHS
Research Focus: Pharmacoepidemiology, Diabetes, HIV
Joseph Hwang is a general internal medicine fellow at the Johns Hopkins University School of Medicine. He completed his M.D. at Case Western Reserve University School of Medicine and internal medicine residency at the University of Pittsburgh Medical Center. He also received M.Sc. in epidemiology and has studied prescription drugs and health outcomes in chronic diseases. His research interests include pharmacoepidemiology, diabetes, and HIV.
Corey Joseph, MPH
Advisor: G. Caleb Alexander, MD, MS
Research Focus: Causal inference and machine learning applications to pharmacoepidemiology
Corey Joseph is a PhD student in the Department of Epidemiology. Over the past three years, he led global evidence generation activities for the approval and reimbursement of pharmaceutical drugs in the ophthalmology, gastroenterology, and oncology therapeutic areas at Takeda Pharmaceuticals. Before Takeda, Corey held roles of increasing responsibility in the real world evidence group at IQVIA, and in the upper aerodigestive oncology group at the Johns Hopkins University School of Medicine. He obtained his MPH from the Boston University School of Public Health and his Bachelors of Science in Public and Community Health from the University of Maryland. His research interests are in the intersection of causal inference and machine learning methodologies.
Michael Kennedy, PharmD
Advisor: Caleb Alexander, MD, MS
Research Interests: Pharmacoepidemiology, Addiction and Overdose in Community Pharmacy Settings
Michael is currently a part-time MPH student and a Bloomberg American Health Initiative Fellow, with a focus area in Addiction and Overdose. He has spent most of his career as a pharmacist for CVS Health in the Detroit area. Most recently, Michael has transitioned to a pharmacy advisor within their corporate office, working with a product development team in pharmacy operations. In this role he helps research, develop, and implement new programs and initiatives with an aim to achieve better health outcomes for patients and communities. His research interests include pharmocoepidemiology and health behaviors as they relate to expanding the role of the community pharmacist in identifying and preventing addiction and overdose.
Banda A Khalifa, MD, MH, MBA
Advisor: G. Caleb Alexander, MD, MS
Research Interest: Vaccine science policy and pharmaceutical outcomes and effectiveness
Dr. Banda Khalifa is an award-winning physician and a doctoral (Ph.D.) student in the department of epidemiology who works as a vaccine regulatory and policy analyst at the Johns Hopkins International Vaccine Access Center (IVAC). He was an MPH & MBA Johns Hopkins Sommer Scholar and a Center Scholar focused on epidemiology and biostatistics with a certificate in Pharmacoepidemiology from 2018 to 2020. His MBA emphasis was in health systems, finance, and management, and he graduated as a Beta Gamma Sigma (International Business Honor Society) member. Dr. Banda has led and managed teams in government and non-governmental organizations through transformations that resulted in the organization's go-big objective being realized. He joined the Ghana Armed Forces in 2014 and won the Chief of the Defense Staff Award by Ghana's president after commissioning as the overall best graduating cadet. He led the medical team for Ghana's Aviation team on four UN Peacekeeping missions. Dr. Banda worked as a manager for the Covid-19 response program within the Baltimore City Health Department. Dr. Banda formerly served as the vaccine and health delivery advisor for the Tony Blair Institute for Global Change. Dr. Banda received the 2022 alum impact award at the University of Ghana School of Medicine and Dentistry's 60th-anniversary celebration. His research interests include vaccination science policy, effectiveness, and outcomes research.
Randall Kuffel, ScM
ADVISOR: HEMALKUMAR MEHTA, PHD
RESEARCH FOCUS: PHARMACOEPIDEMIOLOGY, CLINICAL DECISION-MAKING
Randall Kuffel is a PhD student in the Department of Epidemiology. Prior to joining BSPH, he worked as a research associate at the San Francisco VA Health Care System in the Department of Psychiatry. His research has focused on the epidemiology of late-life suicide in the US veteran population, with emphases on antipsychotic medications, frailty, and PTSD.
Aster Meche, MPH
Advisor: John Jackson, ScD & G. Caleb Alexander, MD, MS
Research Focus: Pharmacoepidemiology, drug utilization
Aster Meche is a PhD student in the Department of Epidemiology. For the past four years, she worked at Pfizer Inc where she supported real-world evidence generation activities for pharmaceutical drugs in development and post approval, specifically in oncology and inflammation and immunology therapeutic areas. Aster obtained her MPH from Columbia University Mailman School of Public Health and her Bachelors of Science in Public Health Sciences from University of California, Irvine. Her research interests include measures of quality of care, pharmacy access, utilization to medications, and treatment effectiveness.
Lijuan Zeng, MHS
Advisors: Stephan Ehrhardt, MD & Sheriza Baksh, PhD
Research Focus: Design and conduct of clinical trials, benefit-risk assessment, pharmacoepidemiology
Lijuan Zeng is a PhD student in Epidemiology. She previously worked at Statistics Collaborative, Inc. for several years as a biostatistician, providing statistical services regarding study designs and analyses of clinical research to pharmaceutical and biotech companies. She also served as an independent reporting statistician for Data and Safety Monitoring Boards for mainly industry-sponsored phases 2 and 3 clinical trials. Lijuan obtained her MHS in Epidemiology from Johns Hopkins Bloomberg School of Public Health and her Bachelor of Science in Pharmaceutical Science from Fudan University. Her research interest includes design and conduct of clinical trials, benefit-risk assessments, and pharmacoepidemiology.
Jinqi Zhan, MPH
ADVISORS: Douglas A. Jabs, M.D., M.B.A., M.S. & Ann Margret Ervin, Ph.D., MPH.
RESEARCH FOCUS: ADAPTIVE DESIGN CLINICAL TRIALS, REGULATORY SCIENCE
Jinqi Zhan is a Ph.D. student in the Clinical Trials and Evidence Synthesis Track at the Department of Epidemiology. She completed her MPH (Chronic Disease Epidemiology) at Yale University and worked in a biotech company for several years before starting her doctoral training. She gained experience in clinical trial regulatory submissions, Institutional Review Board applications, data monitoring, and patient recruitment in the US and Asia through executing an international oncology trial. For her future research, she hopes to explore adaptive design clinical trials, precision medicine, and regulatory science in cancer drug development.
Elizabeth Szymanski
ADVISOR: Dr. Ann-Margret Ervin, MPH,PHD
RESEARCH FOCUS: PHARMACOEPIDEMIOLOGY, REAL-WORLD EVIDENCE, AND PATIENT ADVOCACY
Elizabeth Szymanski is an MHS candidate in the Epidemiology Department, specializing in Clinical Trials and Evidence Synthesis. She completed a BA in Neuroscience at Oberlin College, Ohio, with a focus on psychopharmacology, addiction science, and cognitive science. Prior to her time at Johns Hopkins, she worked as a Scientific Content Specialist for a life science and healthcare marketing agency. She conducted biostatistics research in genomic neurobiology at the University of Michigan School of Public Health and served as a research associate for the Cognitive Development Laboratory at the University of California, San Diego. She is interested in pharmacoepidemiology, real-world evidence, and patient advocacy.
Xinyi Sun
ADVISOR: Hemalkumar B. Mehta, PhD
RESEARCH FOCUS: PHARMACOEPIDEMIOLOGY, CAUSAL INFERENCE
Xinyi Sun earned her Bachelor Degree of Medicine with a major in Public Health from Sun Yat-sen University, China. Throughout her undergraduate study, she gained valuable knowledge and skills in epidemiological research and data analysis. Her bachelor’s degree thesis focused on studying the effects of switching ART regimens on renal function among people living with HIV. She is currently pursuing her MHS degree in Epidemiology, where her focus lies in causal inference methodology. Her specific interest extends to the application of these methods in pharmacoepidemiology.
Qilin Deng
ADVISORS: G. CALEB ALEXANDER, MD, MS
RESEARCH FOCUS: PHARMACOEPIDEMIOLOGY, HEALTHY LIFESTYLE INTERVENTIONS
Qilin Deng is an MHS student at Johns Hopkins Bloomberg School of Public Health, focusing on epidemiology with a keen interest in pharmacoepidemiology and the impact of lifestyle on diseases. Before joining Hopkins, Qilin earned a Bachelor of Medicine, specializing in Preventive Medicine. Her future research interests include delving into more real-world evidence, conducting benefit-risk assessments, and engaging in pharmacoepidemiology.
Honest Anaba
RESEARCH INTERESTS: SUBSTANCE USE EPIDEMIOLOGY, PHARMACOEPIDEMIOLOGY, HARM REDUCTION
Dr. Honest Anaba is a certified Addiction Medicine Physician and full-time MPH student. He is the first practising physician within West Africa to achieve certification from the International Society of Addiction Medicine (ISAM). He translates evidence-based treatment programs into patient care for diverse populations in his region. Beyond his clinical practice, he actively participates in educational, advocacy, and community engagement efforts to enhance addiction treatment and prevention.
Dr Anaba brings particular expertise in behavioural addictions and is a certified co-occurring Gambling specialist. His contributions span beyond the West African landscape. He leads research projects and subcommittee initiatives for ISAM's New Professionals Exploration, Training & Education. He is part of the ISAM Global Expert Network developing telemedicine protocols for Medication for Opioid Use Disorder (TMOUD). He is a peer reviewer for the Journal of Clinical Psychiatry and serves on the Anti-Racism, Diversity, Equity, and Inclusion committee at the American College of Academic Addiction Medicine.
Hsiu-Yi Liao
Research Interests: Pharmacoepidemiology and drug safety, effectiveness and utilization
Hsiu-Yi earned her Bachelor degree of Science with a major in Nursing from National Cheng Kung University in Taiwan and is currently pursuing an MPH degree at Johns Hopkins Bloomberg School of Public Health. Prior to her time at Hopkins, she worked as a registered nurse in a hospice ward and gained internship experience in drug development using AI technology.
Sissi Jingjing Sun, DrPH, MHS, MSc, MBA
Advisors: Jodi Segal, MD, MPH & Caleb Alexander, MD, MS
Research Focus: Pharmacoepidemiology, Drug Safety and Effectiveness, Real-World Evidence (RWE), Clinical Trials, Regulatory Science, and Health Economics and Outcomes Research (HEOR)
Dr. Sun received her DrPH and MHS from the Johns Hopkins Bloomberg School of Public Health, an MSc from the Johns Hopkins Carey Business School, and an MBA from the University of Hong Kong. With over a decade of experience in the medical industry, including roles in pharmaceutical marketing and strategic development for medical devices, she has gained extensive practical knowledge in drug safety and efficacy, particularly in ophthalmological, cardiovascular, and respiratory diseases. Shifting her career focus from China to the U.S. and global markets, she is now specializing in pharmacoepidemiology.
Her research interests stem from her industry experience, where she witnessed the complexities of ensuring drug safety and efficacy across diverse markets. Dr. Sun aims to investigate the utilization, effectiveness, and safety of medications and medical devices, with a strong emphasis on real-world evidence to mitigate risks associated with pharmaceutical treatments. Her research interests include examining the use of medicines to treat heart, lung, and blood diseases in the United States. She is committed to applying her expertise to improve patient outcomes and quality of life.
Ellen Barnie Peprah, MD
Ellen Peprah is a dual MPH/MBA student at Johns Hopkins University on the Health, Technology and Innovation pathway. After working in rural and urban Ghana as a medical doctor and experiencing the limited treatment options available for patients, she pivoted into public health to address systemic healthcare challenges.
Prior to graduate school, she worked as a researcher at the NIHR Global Health Research Center for Non-Communicable Diseases and served as CYHN coordinator at the Commonwealth Secretariat. Her professional interests include clinical development, regulatory affairs, and patient safety, aligning with her goal of a career in pharmaceutical medicine.
Joseph Kannarkat, MD
Dr. Joseph Kannarkat is an internal medicine resident. He has previously published articles on drug regulatory and health policy in venues like The New England Journal of Medicine, The Journal of the American Medical Association, and The Brookings Institution. His research interests include studying the regulation, use, and reimbursement of therapeutics and the role of regulatory agencies (i.e., FDA and CMS) in these processes. Prior to his medical training, he worked with England’s National Health Service in Cambridgeshire to study health system restructuring and explored innovative approaches to healthcare provision in Kenya. He received an MPhil in Public Policy as a Kanders Churchill Scholar at the University of Cambridge and a Master of Global Affairs at Tsinghua University as a Schwarzman Scholar. Joseph completed his undergraduate education in economics and neuroscience at the University of Pittsburgh.
Gbolahan Olatunji, MD, FRSPH
Research focus: Pharmacoepidemiology of Cardiometabolic disorders; infectious disease and vaccine policy
Gbolahan Olatunji, is a trained physician with over three years of practice and a Fellow of the Royal Society for Public Health. He is an MPH Candidate at the Bloomberg School and a Dean and MPH scholar pursuing the Epidemiology and Biostatistics track. He is an accomplished author with over 90 peer-reviewed publications in international journals; he jointly leads an international research network known as the Emerging Researchers Network which serves to drive more quality research output in Africa. His research has been focused on Cardiovascular health and infectious diseases. Some of his published works include articles on Inclisiran siRNA technology in managing dyslipidemia, the role of semaglutide in heart failure, and Oxford's R21/Matrix-M vaccine, among others. His policy-related articles have also been featured in the Lancet journal. He is particularly interested in learning more about clinical trials in pharmacoepidemiology of novel therapies in cardiometabolic disorders and infectious diseases, as he strives to save lives “millions at a time” and “millions in a lifetime”.
Graduated Scholars
Enoch Abbey, MD, MPH
Adviser: John Jackson, ScD
Research Focus: Pharmacoepidemiology
Ekta Agarwal, MPH
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Drug Safety and Adherence
Taiwo Akindahunsi, MD, MPH
Adviser: Sabina Haberleen, PhD
Research Focus: Pharmacoepidemiology, Clinical Trials and Drug Safety and Surgical Outcomes in Neurosurgery
Kayte Andersen, MSc
Adviser: G. Caleb Alexander, MD, MS & Jodi Segal, MD, MPH
Research Focus: Use Beyond the Evidence Base: An Evaluation of Pharmacotherapy During COVID-19
Shirin Ardeshirrouhanifard, PharmD, MPH, PhD
Adviser: Hemalkumar Mehta, PhD & Jodi Segal, MD, MPH
Research Focus: Safety and effectiveness of medications in cancer population
Melat Asebot, MD, MPH
Research Focus: Pharmacoepidemiology, Clinical Trials, Drug Safety and Effectiveness
Samuel Kwakye Ayeh, MBChB (MD), MPH
Adviser: Jonathan Golub, PhD
Research Focus: Risk factors associated with positive latent tuberculosis test in pregnant women
Sheriza Baksh, PhD, MPH
Adviser: G. Caleb Alexander, MD, MS & Stephen Ehrhardt, MD
Research Focus: Pharmacoepidemiology
Daniah Basodan, MBBS, FRCPC
Adviser: Mara McAdams DeMarco, PhD, MS
Chelsea Canan, MPH, PhD
Adviser: Bryan Lau, PhD
Research Focus: Epidemiologic Methods; Prescription Opioid Misuse
Jessica Chasler, PharmD, BCPS
Adviser: Jodi Segal, MD, MPH
Research Focus: Pharmacoepidemiology
Lian-Yu Chen, MD, PhD
Adviser: Ramin Mojtabai, MD, PhD
Research Focus: Substance Use Disorders, Service Utilization and Psychiatric Comorbidities
Audrey Cheng, MPH
Research Focus: Pharmaceutical policy and law
Francine Chingcuanco, MHS
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Utilization of Generic Medicines
Stacy Elder Dalpoas, PharmD, MPH, BCPS
Adviser: Jodi Segal, MD, MPH
Matthew Daubresse, MHS
Adviser: Mara McAdams Demarco, PhD, MS
Research Focus: Impact of Policy Interventions on the Utilization of Prescribed Controlled Substances
Mindi DePaola, MSPH
Adviser: Victoria B. Chou, PhD, MS
Research Focus: Drug Utilization and Access in Underserved Populations
Leigh Efird, PharmD, MPH, BCPS
Adviser: Sherita Hill Golden, MD, MHS
Research Focus: Hospital Drug Utilization
Ijeamaka Ezebilo, MD, MPH
Adviser: Jodi Segal, MD, MPH
Research Focus: Pharmacoepidemiology
Busola Fadojutimi, B. Pharm, MPH, MBA
Adviser: Stefan Baral, MD & David Chin, MD, MBA
Research Focus: Disease epidemiology, drug safety and adverse drug reactions
Kevin Fain, DrPH, JD, MPH
Adviser: Carlos Castillo-Salgado, MD, DrPH, JD
Research Focus: Safety of Opioid Use in the Elderly
Haley Gibbs, PharmD, MPH, BCPS
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Therapeutic Drug Monitoring
Gillian Gresham, MSc, PhD
Adviser: Kay Dickersin, PhD
Research Focus: Clinical Trials and Evidence Synthesis
Mengdong He, MHS
Adviser: Edgar R. Miller, MD, PhD
Research Focus: Drug Utilization and Effects
Catherine Hwang, MSPH
Adviser: G. Caleb Alexander, MD, MS
Research Focus:Prescription Drug Utilization and Abuse-Deterrent Formulations
Geetha Iyer, MBBS, MD, ScM
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Drug Utilization and Pharmacovigilance
Myles Jackson, MHS
Research Focus: Pharmacoepidemiology, comparative effectiveness, drug safety
Shiyin Jiao, MHS
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Quality of Pharmaceutical Care, Patient Outcomes, Structure of Clinical Practice
Sindhura Karlapudi, MBBS, MPH
Adviser: G. Caleb Alexander, MD, MS
Taruja Karmarkar, MHS, PhD
Adviser: Darrel J. Gaskin, PhD
Research Focus: Pharmacoeconomics, Decision Modeling, Pharmaceutical Policy, and Patient Outcomes Research
Christopher Kaufmann, PhD, MHS
Advisers: Ramin Mojtabai, MD, PhD & Adam Spira, PhD
Research Focus: Sedative-Hypnotic Use Among the Elderly
Shelby Kemper, PharmD, MPH
Adviser: Jodi Segal, MD, MPH
Research Focus: Quality, Access, Availability and Utilization of Pharmaceuticals in Low and Middle Income Countries
Jeongmin (Hana) Kim, PharmD, ScM
Adviser: Jodi Segal, MD, MPH
Research Interests: Pharmacovigilance, signal detection, drug risk/benefit evaluation, post-marketing surveillance, real-world evidence
Martha Tushemereirwe Kirabo, MD, MPH
Adviser: Janet Holbrook, PhD
Zaina Kiragu, MPharm, MPH
Adviser: Alain K. Koffi, MD, PhD
Kimberley Lee, MD, MHS
Adviser: Jodi Segal, MD, MPH
Research Focus: Pharmacoepidemiology
Seoyoung (Celina) Lee
Shanshan Lin, ScM
ADVISER: CALEB ALEXANDER, MD, MS & JODI SEGAL, MD, MPH
RESEARCH INTERESTS: PHARMACOEPIDEMIOLOGY, REAL-WORLD EVIDENCE
Yi-Chen Liu, MHS
Adviser: Mara McAdams Demarco, PhD, MS
Research Focus: Pharmacoepidemiology
Xintong Li, BSc
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Pharmacoepidemiology, drug safety, effectiveness and utilization
Eleanor Lucas, BA
Adviser: Aditi P. Sen, PhD
Nune Makarova, MD, MPH
Adviser: Debra Roter, DrPH, Professor
Omar Mansour, MHS
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Pharmacoepidemiology, Drug Utilization
Sathiya Priya Marimuthu, MBBS, MHS
Advisers: Brent Petty, MD & Jodi Segal, MD, MPH
Research Focus: Drug Safety and Pharmacoepidemiology
Kathryn Marwitz, PharmD, MPH
Adviser: Jodi Segal, MD, MPH
Research Focus: Pharmacoepidemiology and Pharmaceutical Policy
Morgan Maziarz, MHS
Adviser: Ann-Margaret Ervin, PhD
Research Focus: Pharmacoepidemiology, drug utilization, clinical trials
Yidnekachew Mogessie, MD, MPH, MBA
Research Focus: Pharmacoepidemiology, clinical trials, health economics and outcomes research, surgical outcomes research
Alexander Moran, MSPH
Adviser: Lawrence Moulton, PhD
Research Focus: Drug Utilization and Adherence
Morgane Mouslim, DVM, ScM
Adviser: Jodi Segal, MD, MPH & G. Caleb Alexander, MD, MS
Research Focus: Pharmacoepidemiology
Joelynn Muwanga, MPH
Research interests: Drug utilization, effectiveness, safety and medication adherence
Remington Nevin, DrPH, MD, MPH
Adviser: Francesca Litow, MD, MPH
Research focus: Occupational Drug Safety and Pharmacovigilance
Richard Dunku Nudotor, MB CHB, MPH
Adviser: Mara McAdams DeMarco, PhD, MS
Research Focus: Clinical Trials, Pharmacoepidemiology and Drug Safety, Surgical Outcomes in Pancreatic and Bariatric Surgery
Ken Ogasawara, PhD, MPH
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Pharmacoepidemiology, Regulatory Science
Gaurvika ML Nayyar, MPH, MBA
Adviser: David Peters, MD, DrPH, MPH
Research focus: Pharmaceutical Quality, Emerging Markets, Health Outcomes, and Access
David Procaccini, PharmD, BCPS, CACP
Adviser: Gerard Anderson, PhD
Research Focus: Health Policy and Medication Safety in Pediatric Population
Yao (Lucy) Qiao, MPH, MSc, PhD
Advisers: G. Caleb Alexander, MD, MS & John W. Jackson, ScD
Research Focus: Pharmacoepidemiology
Emaan Rashidi, MHS
Adviser: Stephan Ehrhardt, MD
Research Focus: Pharmacoepidemiology & Psychiatric Epidemiology
Kevin Riggs, MD, MPH
Research focus: Prescription Drug Costs
Michelle Robinson, PharmD, MPH
Adviser: Jill Marsteller, PhD
Research Focus: Drug utilization, public health policy, medication safety
Cindy Sagoe, BPharm, MPH
Adviser: Irene Murimi, PhD
Marissa Seamans, PhD, MSPH
Adviser: Elizabeth Stuart, PhD
Research Focus: Household Patterns of Prescription Medication Use
Alex Secora, MPH, PhD
Advisers: G. Caleb Alexander, MD, MS & Josef Coresh, MD
Research Focus: Pharmacoepidemiology
Ashton Shaffer
Adviser: Mara McAdams Demarco, PhD, MS
Research Focus: HIV+ Liver Transplant Candidates and Recipients
Mariana Socal, MD, MSc, MPP, PhD
Adviser: Antonio Trujillo, MPP, PhD
Research focus: Pharmaceutical Access and Utilization in Low- and Middle-Income Countries
Jingwen Tan, PhD, ScM
Research focus: Epidemiology of Drug-Induced Morbidity and Mortality
Sangeeta Tandon, PharmD, MPH
Adviser: Andrea Ruff, MD
Research Focus: Pharmaceutical Quality, Access, and Affordability in Low Income Countries
Sarah Tanveer, MA
Advisers: Barry Zirkin, PhD & G. Caleb Alexander, MD, MS
Research Focus: Migraine/Headache disorders, Evidence Synthesis, Comparative Effectiveness Research, Pharmacoepidemiology
Rediet Tekalign, MD, MPH
Research Focus: Pharmacoepidemiology, clinical trials, biologic drug safety, effectiveness in pediatrics
Carolyn Tieu, PharmD, MPH
Adviser: G. Caleb Alexander, MD, MS
Research focus: Pharmacoepidemiology, Comparative Effectiveness Research, Patient Outcomes Research
Phuong Tran, PharmD, MPH
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Pharmacoepidemiology, Cancer Epidemiology, Genetics and Epigenetics
Chinenye Ugoji, BPharm, MPH, PhD
Advisers: Elizabeth Platz, ScD & Lorraine Dean, ScD
Research Focus: Pharmacoepidemiology, Cancer, HIV, Outcomes research
Siddhi Umarje, PharmD
Adviser: Catherine Sutcliffe, PhD
Shilpa Viswanathan, PhD, MS, BPharm
Adviser: Lisa P. Jacobson, ScD
Research Focus: Effects of Concomitant Medication Use on Adherence to Highly Active Antiretroviral Therapy (HAART)
Amelia Wallace, MS
Adviser: Elizabeth Selvin, PhD, MPH & Morgan Grams, MD, PhD
Research Focus: Pharmacoepidemiology
Jiajun Wen, MD, MPH, ScD
Adviser: Janet Holbrook, PhD, MPH, MS
Research Focus: Pharmacoepidemiology and Clinical Trials
Xuya Xiao, MHS
Adviser: Caleb Alexander, MD, MS & Hemalkumar Mehta, PhD
Research Focus: Pharmacoepidemiology, drug safety, drug utilization
Yunwen Xu, MHS
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Pharmacoepidemiology, Drug Utilization, Outcomes Research
Jeffrey Yu, MHS
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Pharmacoeconomics, Pharmacoepidemiology, Pharmaceutical Policy, Decision Modeling
Hanzhe Zhang, MHS
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Pharmacoepidemiology
Meijia Zhou, MHS
Adviser: G. Caleb Alexander, MD, MS
Research Focus: Drug Utilization and Safety
Fasika Molla Abreha, MD, MPH
Research Focus: Pharmacoepidemiology, Drug Access, Safety and Effectiveness
Allie Babyak, MHS
Advisor: Jeromie Ballreich, MHS, PHD
Research Focus: Pharmaceutical policy, pharmacoeconomics
Umaima Tahir Banda, BSc, MPH
Research Focus: Pharmacoepidemiology, Safety and effectiveness of vaccines and biologics
Cheryl Chia, PhD, MPH/MBA
Advisor: G. Caleb Alexander, MD, MS
Research Focus: Public health policy and pharmacoeconomics
Michael Chiu, ScM
Sanika Chivate, MHS
Research Focus: Infectious disease epidemiology and pharmacoepidemiology
Grace Gahlon, ScM
Research Focus: Class II and III medical devices, real-world evidence, regulatory science
Scott Goldman, MPH/MBA
Advisor: Matthew D. Eisenberg, PhD
Shota Hasui, MA, MPH
Research Focus: Pharmacoeconomics, Real World Evidence, Comparative Effectiveness, Health Technology Assessments, Meta-research/Critical Appraisal
Jamie Heyward, MPH, PhD
Advisors: Jodi Segal, MD, MPH & Hemalkumar Mehta, PhD
Research focus: Pharmacoepidemiology, regulatory science
Ozi Iyalomhe, MPH
Advisor: Jung-Im Shin, MD, PhD
Research Focus: Pharmacoepidemiology, drug utilization
Kyungah Kim, PharmD, MPH
Advisor: Ann-Margret Ervin, PhD, MPH
Gauri Kore, MBBS
Advisor: Shruti Mehta, PhD
Research Interests: Infectious disease epidemiology, pharmacoepidemiology
Lipin Lukose, PharmD, MPH
Research Interests: Pharmacoepidemiology, Medication Access and Safety
Kriti Rastogi, MHS
Advisor: Jeanine Parisi, PhD, MA & Elise Weerts, PhD
Research Focus: Behavioral pharmacology of alcohol, substance use in underserved populations
Rupshikha Sen, MHS
Advisor: Keri Althoff, MPH, PhD
Biruk Teshome, MD, MSc, MPH
Advisor: Yvonne Commodore-Mensah, PhD, MHS
Astha Wahi, BDS, MBA, ScM
Advisor: Catherine Sutcliffe, PhD, Maria Deloria Knoll, PhD
Research Focus: Infectious disease epidemiology, pharmacoepidemiology, vaccine science and policy, real-world evidence use
Daniel Willie-Permor, MD, MPH
Advisor: Conan Dickson, PhD
Research Focus: Artificial intelligence and machine learning in the drug discovery/manufacturing processes
Ziang (Bill) Zhou, BS, MHS
Advisor: Hemalkumar Mehta, PhD
Research Focus: Drug-drug interactions for concomitant use of DOACs and statins